Sesen Bio

Is working on developing a new treatment for bladder cancer.

Launch date

2010

Employees

Market cap

Enterprise valuation

(CAD65m) (Public information from Mar 2023)

Cambridge Massachusetts (HQ)

Date	Investors	Amount	Round
-	JAFCO Japan	N/A	-
Mar 2010	Third Rock Ventures Flagship Pioneering	$35.0m	Series A
May 2012	JAFCO Asia Third Rock Ventures Flagship Pioneering	$20.0m	Early VC
Feb 2014	N/A	N/A	IPO
Nov 2014	N/A	$20.0m	Post IPO Equity
Mar 2015*	Cowen Group	$40.0m	Post IPO Equity
Nov 2017	N/A	$8.0m	Post IPO Equity
Sep 2022*	Carisma Therapeutics	N/A	Acquisition
Total Funding		CAD75.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Sesen Bio